Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
about
Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients.
P2860
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@en
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@nl
type
label
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@en
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@nl
prefLabel
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@en
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@nl
P2093
P2860
P50
P356
P1433
P1476
Therapeutic dosages of aspirin ...... the ribosome biogenesis rate.
@en
P2093
Davide Treré
Elisa Brighenti
Ferdinando Antonino Giannone
Lorenzo Montanaro
Massimo Derenzini
P2860
P304
63226-63241
P356
10.18632/ONCOTARGET.11441
P407
P577
2016-08-20T00:00:00Z